Impax Says Pfizer's Detrol Patent Suit Is Baseless
Impax Laboratories Inc. President and Chief Executive Larry Hsu has alleged that Pfizer Inc.'s recent patent suit against Impax over urinary incontinence treatment Detrol LA is a ploy to fend off...To view the full article, register now.
Already a subscriber? Click here to view full article